Merck pays $250M to license Moderna cancer vaccine
Bio Pharma Dive
OCTOBER 12, 2022
The drugmaker’s decision to grab rights to the shot deepens its ties with the COVID-19 vaccine developer and comes weeks before a key data release.
Wed.Oct 12, 2022
311 
Novo Nordisk submitting once-weekly insulin to FDA following Phase III success
Pharmaceutical Technology
OCTOBER 12, 2022
Novo Nordisk has recently completed its six-part ONWARDS Phase III trial, as ONWARDS 5 reached its primary endpoint with Icodec demonstrating non-inferiority in reducing hemoglobin A1C (HbA1c) in patients with type 2 diabetes (T2D) at week 52 in comparison to once-daily basal insulin analogs. This successful outcome for insulin icodec increases the likelihood of achieving Food and Drug Administration (FDA) approval next year, which will establish Novo Nordisk’s dominance in the basal insulin mar
Join 32,000+
Insiders
Sign Up for our Newsletter
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Omicron boosters from Pfizer, Moderna cleared by FDA for younger children
Bio Pharma Dive
OCTOBER 12, 2022
Pfizer's reformulated vaccine is now authorized for use in children at least 5 years of age, while Moderna's will be available for kids as young as 6.
Neumora raises funds for precision neuro therapies development
Pharmaceutical Technology
OCTOBER 12, 2022
Neumora Therapeutics has raised $112m in a Series B financing round to advance its new precision medicine candidates pipeline for neuropsychiatric disorders and neurodegenerative diseases. New and existing investors including F-Prime Capital, Altitude Life Science Ventures, Mubadala Capital, Amgen, Exor Ventures, ARCH Venture Partners, Invus, Abu Dhabi Growth Fund (ADG), Newpath Partners, Polaris Partners, as well as other undisclosed investors have participated in the financing round.
Unlocking Excellence: How Catalent Is Transforming Japan’s Clinical Research
Advertisement
Planning on running clinical trials in Japan? How can you reliably supply these studies? Discover Catalent’s clinical supply packaging facility in Shiga, Japan. Strategically located between Tokyo and Osaka, and one of largest in Japan, this 6,000 square meter facility offers comprehensive services including primary and secondary clinical packaging and labelling, comparator sourcing, cold chain storage, local and global distribution, local language support and white glove service to support stud
Ascidian starts up with $50M and a twist on RNA editing
Bio Pharma Dive
OCTOBER 12, 2022
The startup, run by Translate Bio cofounder Romesh Subramanian, believes its RNA “exon editing” approach could have long-lasting effects without the risks that come with editing DNA.
October 12, 2022: Ethics and Regulatory Grand Rounds Series Continues This Friday
Rethinking Clinical Trials
OCTOBER 12, 2022
This Friday’s PCT Grand Rounds will feature the next installment of our special Grand Rounds series, Ethical & Regulatory Dimensions of Pragmatic Clinical Trials. Joe Ali, Tanya Matthews, and Leslie Crofford will present “Responding (or Not) to Signals of Potential Clinical Significance in Pragmatic Clinical Trials.” The Grand Rounds session will be held on Friday, October 14, 2022, at 1:00 pm eastern.
Sign up to get articles personalized to your interests!
Clinical Research Informer brings together the best content for clinical researchers from the widest variety of industry thought leaders.
More Trending
Poland’s pharma industry IT recruitment activity rises 17.4% in September 2022
Pharmaceutical Technology
OCTOBER 12, 2022
Poland’s pharma industry registered a 17.4% rise in IT hiring activity in September 2022 when compared with the previous month, according to GlobalData’s Job Analytics database. The industry’s overall hiring increased by 11.33% in September 2022 when compared with August 2022. Out of the pharma industry’s total hiring activity, IT jobs claimed a 13.35% share in September 2022, recording an increase of 1.8% over the last three-month average share.
Opinion: Maternity care in the U.S. is in crisis. It’s time to call the midwife
STAT News
OCTOBER 12, 2022
After pushing for several hours, my patient looks exhausted but happy, clutching her seconds-old newborn to her chest. As I help her put her baby to breast for the first time, she isn’t thinking about anything other than the tiny human blinking up at her. As well she shouldn’t.
UK pharma industry IT recruitment activity rises 11.4% in September 2022
Pharmaceutical Technology
OCTOBER 12, 2022
The UK’s pharma industry registered an 11.4% rise in IT hiring activity in September 2022 when compared with the previous month, according to GlobalData’s Job Analytics database. The industry’s overall hiring increased by 167.52% in September 2022 when compared with August 2022. Out of the pharma industry’s total hiring activity, IT jobs claimed a 1.8% share in September 2022, recording a decrease of 2.4% over the last three-month average share.
Human neurons implanted in a rodent’s brain lead a rat to water — and make it drink
STAT News
OCTOBER 12, 2022
The scientist flicked on a laser, filling the rat’s brain with blue light. The rodent, true to its past two weeks of training, scampered across its glass box to a tiny spout, where it was duly rewarded with a drink of water. From the outside, this would appear to be a pretty run-of-the-mill neuroscience experiment, except for the fact that the neurons directing the rat to its thirst-quenching reward didn’t contain any rat DNA.
The New Age of Decentralized Clinical Trials
Advertisement
White paper that delves into the complex topic of Decentralized Clinical Trials and how to master them within the confines of FDA Regulations
Switzerland’s pharma industry IT recruitment activity rises 47.7% in September 2022
Pharmaceutical Technology
OCTOBER 12, 2022
Switzerland’s pharma industry registered a 47.7% rise in IT hiring activity in September 2022 when compared with the previous month, according to GlobalData’s Job Analytics database. The industry’s overall hiring increased by 10.96% in September 2022 when compared with August 2022. Out of the pharma industry’s total hiring activity, IT jobs claimed a 3.99% share in September 2022, recording an increase of 0.79% over the last three-month average share.
How this Brazilian doc got nearly every person in her city to take a COVID vaccine
NPR Health - Shots
OCTOBER 12, 2022
Dr. Gabriela Kucharski's city of Toledo had virtually no vaccines. And it's a bastion of support for Brazil's vaccine skeptic president. Here's why that didn't matter.
US pharma industry IT recruitment activity drops 6.6% in September 2022
Pharmaceutical Technology
OCTOBER 12, 2022
The US’s pharma industry registered a 6.6% drop in IT hiring activity in September 2022 when compared with the previous month, according to GlobalData’s Job Analytics database. The industry’s overall hiring is decreased by 0.92% in September 2022 when compared with August 2022. Out of the pharma industry’s total hiring activity, IT jobs claimed a 1.73% share in September 2022, recording a decrease of 0.16% over the last three-month average share.
Millions of Americans are losing access to maternal care. Here's what can be done
NPR Health - Shots
OCTOBER 12, 2022
A report from the nonprofit March of Dimes finds that 36% of counties in the U.S. are "maternity care deserts," meaning they have no obstetric hospitals or birth centers and no obstetric providers. (Image credit: March of Dimes/US Health Resources and Services Administration.
Roles and Responsibilities of Specialized Clinical Supply Experts
Advertisement
When selecting a clinical supply provider, consideration often focuses upon the manufacturing, packaging, storage and distribution capabilities available that will, at face-value, be sufficient to meet the needs of the sponsor and their trial. However, there are human-based and knowledge-driven factors that are often overlooked that go beyond these basic physical capabilities and are integral to the development and delivery of high performing clinical supply chains.
AstraZeneca’s IT hiring activity declines 13.2% in September 2022
Pharmaceutical Technology
OCTOBER 12, 2022
UK-based company AstraZeneca’s IT hiring declined 13.2% in September 2022 when compared with the previous month, according to GlobalData’s Job Analytics database. The company’s overall hiring activity declined by 6.31% in September 2022 when compared with August 2022. IT jobs claimed a 7.97% share in the company’s total hiring activity in September 2022, and recorded a 0.35% decline over the last three-month average share.
Omicron boosters for kids 5-12 are cleared by the FDA. The CDC's OK is the last step
NPR Health - Shots
OCTOBER 12, 2022
Tweaked boosters rolled out for Americans 12 and older last month, modified to target today's most common and contagious variant. The latest move may expand protection before an expected winter wave. (Image credit: Rogelio V.
Johnson & Johnson’s IT hiring activity declines 9.3% in September 2022
Pharmaceutical Technology
OCTOBER 12, 2022
US-based company Johnson & Johnson’s IT hiring declined 9.3% in September 2022 when compared with the previous month, according to GlobalData’s Job Analytics database. The company’s overall hiring activity increased by 1.25% in September 2022 when compared with August 2022. IT jobs claimed a 3.66% share in the company’s total hiring activity in September 2022, and recorded a 0.48% decline over the last three-month average share.
Latina immigrants may be exposed to Spanish-language disinformation about abortion
NPR Health - Shots
OCTOBER 12, 2022
Doctors and reproductive rights advocates are seeing a surge in disinformation about abortion targeting the Latino community. Some worry that this may dissuade some from seeking medical care.
The New Age of Decentralized Clinical Trials
Advertisement
This new white paper defines and details the impact of Decentralized Clinical Trials on the Pharmaceutical industry and how the impact can be measured along with steps companies can take to ensure adoption.
MerckInc’s IT hiring activity rises 9.3% in September 2022
Pharmaceutical Technology
OCTOBER 12, 2022
US-based company MerckInc’s IT hiring rose 9.3% in September 2022 when compared with the previous month, according to GlobalData’s Job Analytics database. The company’s overall hiring activity increased by 26.42% in September 2022 when compared with August 2022. IT jobs claimed a 5.33% share in the company’s total hiring activity in September 2022, and recorded a 0.66% decline over the last three-month average share.
Eureka Institute to show what translational medicine can do for digital health
pharmaphorum
OCTOBER 12, 2022
It’s no secret that the healthcare system is made up of a panoply of diverse stakeholders, each with their own priorities, incentives, and motivations. Bringing those stakeholders together is an oft-lauded goal, but it’s proved easier said than done. The Eureka Institute, a Syracuse, Italy-based non-profit, is focused on addressing this disparity by providing education, research, and advocacy around the field of translational medicine.
Merck’s IT hiring activity declines 4.4% in September 2022
Pharmaceutical Technology
OCTOBER 12, 2022
Germany-based company Merck’s IT hiring declined 4.4% in September 2022 when compared with the previous month, according to GlobalData’s Job Analytics database. The company’s overall hiring activity declined by 13.71% in September 2022 when compared with August 2022. IT jobs claimed a 9.98% share in the company’s total hiring activity in September 2022, and recorded a 1.97% growth over the last three-month average share.
Human cells in a rat's brain could shed light on autism and ADHD
NPR Health - Shots
OCTOBER 12, 2022
Scientists have devised a new model for studying disorders like autism spectrum disorder and ADHD. It uses clusters of human brain cells grown inside the brain of a rat.
Accelerating Clinical Supply Through Integrated Drug Development
Advertisement
As the development pipeline for new drugs continues to grow, biopharmaceutical companies are re-evaluating how to best manage and balance resources across an increasing number of development projects and complex clinical trials. There are two approaches that can be used to speed a drug from development to clinic faster: timeline compression and parallel processing, but only one that considers the benefits of integrating clinical supply into the overall drug development process.
Toregem BioPharma and WuXi Biologics to partner for antibody development
Pharmaceutical Technology
OCTOBER 12, 2022
Biotech start-up Toregem BioPharma has signed a memorandum of understanding (MoU) with WuXi Biologics to develop the monoclonal antibody, TRG035. Under the MoU, the companies will form a collaboration for the development of TRG035, which targets USAG-1 to treat congenital adentia. As part of the collaboration, Toregem will use WuXi Biologics’ integrated CMC services in cell culture development, cell line development, bioassay development, biologics GMP manufacturing, cell banking and testing ser
Opinion: Listen: The Supreme Court set public health back 50 years. The next term could be even worse
STAT News
OCTOBER 12, 2022
It took the U.S. Supreme Court just seven days last June to set back public health by 50 years. Several cases before the court this term could continue that assault. This week on the First Opinion Podcast, law professor Lawrence O. Gostin explores how these cases — some of which are not explicitly about public health — might worsen the myriad health inequalities that became so evident throughout the Covid-19 pandemic.
India’s pharma industry IT recruitment activity drops 11.1% in September 2022
Pharmaceutical Technology
OCTOBER 12, 2022
India’s pharma industry registered an 11.1% drop in IT hiring activity in September 2022 when compared with the previous month, according to GlobalData’s Job Analytics database. The industry’s overall hiring is decreased by 2.43% in September 2022 when compared with August 2022. Out of the pharma industry’s total hiring activity, IT jobs claimed a 12.95% share in September 2022, recording a decrease of 1.92% over the last three-month average share.
STAT+: Triplet Therapeutics, biotech company focused on Huntington’s, quietly shuts down
STAT News
OCTOBER 12, 2022
A biotech company co-founded by venture capital firm Atlas Venture has shut down after running into problems with its lead drug and raising new funding. Triplet Therapeutics, which was based in Cambridge, Mass., launched in 2019 with a $59 million Series A round from a group of VCs including Atlas, MPM Capital, and Pfizer Ventures.
How Machine Learning Drives Clinical Trial Efficiency
Advertisement
Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.
A blood shortage in the U.K. may cause some surgeries to be delayed
NPR Health - Shots
OCTOBER 12, 2022
Part of the reason for the shortage is that there are fewer donors visiting blood collection centers in cities and towns in the aftermath of the pandemic, the National Health Service said.
Myth Busters: Dispelling Common Myths about Heart Disease, Diabetes and Alzheimer’s
BioSpace
OCTOBER 12, 2022
The internet and “common wisdom” aren’t always right. Here are some of the top myths about three common conditions, and the truth from leading experts in their fields.
Merck gets on board with Moderna cancer vaccine in $250m deal
pharmaphorum
OCTOBER 12, 2022
Shares in Moderna were ticking upwards today after Merck & Co took up an option on a personalised RNA-based cancer vaccine with a payment of $250 million. It is the first time that Merck has exercised an option in its collaboration with the mRNA vaccine specialist, first agreed in 2016 and expanded two years later to include additional candidates.
The Best Way to Answer Salary Interview Questions
BioSpace
OCTOBER 12, 2022
Interviews can be difficult in any field, but especially in a competitive industry like the life sciences. Read on to discover the best way to answer salary interview questions in our guide.
The New Clinical Trial Supply Chain: Resilient, Flexible, and Patient-Centric
Advertisement
The global landscape of clinical trials is rapidly changing as studies become more complex. An increasing number of sponsors are seeking enhanced flexibility in their supply chains to address a variety of clinical supply challenges, including patient demand and reducing delays. Demand-led supply and direct-to-patient distribution are next-generation solutions that are helping to meet these growing needs, allowing for more streamlined processes and patient-centric studies.
Let's personalize your content